Healthcare -
Biotechnology - NASDAQ - US
$ 15.5
-6.4 %
$ 2.25 B
Market Cap
-6.03
P/E
DNLI - NET INCOME
Net Income DNLI - Denali Therapeutics Inc.
-145 M
LAST VALUE
29.31%
2 YEAR CAGR
-32.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR